At day 55, a time point at which most tumors treated with SBRT had started to grow out; significant differences in tumor sizes were still observed between mice treated with SBRT and mice treated with SBRT + α-PD-1/α-CD137 or SBRT + α-CD137 (Fig. 4b). The gene discussed is TNFRSF9; the disease is neoplasm.